ODTX
ODTX
US67613T1043
Odyssey Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 2.976.000 4.472.000
33.5%
Cost of Revenue -- --
--
Gross Profit -- --
--
164.132.000 139.695.000
17.5%
Operating Income -161.156.000 -135.223.000
19.2%
Pretax Income -149.574.000 -128.852.000
16.1%
Net Income Common Stockholders -148.647.000 -130.401.000
14.0%
-- --
--
-- --
--
ende